A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline

Date: 
13 Nov 2017
Source: 
British Journal of Cancer
Audience: 
Professionals
Type of resource: 
Research

Pancreatic carcinoma (PC) is an aggressive malignancy that lacks strategies for early detection. This study aimed to develop a coherent, high-throughput and non-discriminatory pipeline for the novel clinical biomarker discovery of PC.

 

Click here to read the Research article in full